The influence of depression and anxiety symptoms on health-related quality of life in patients with atrial fibrillation and atrial flutter

Journal of Cardiovascular Nursing

Volumn 30, Issue 1, 2015, Pages 66-73

  Akintade, Bimbola Fola ^a   Chapa, Deborah ^b   Friedmann, Erika ^a   Thomas, Sue Ann ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

atrial fibrillation; atrial flutter; health related quality of life

Indexed keywords

AGE; AGED; ANXIETY; ATRIAL FIBRILLATION; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DEPRESSION; EPIDEMIOLOGY; FEMALE; HEART ATRIUM FLUTTER; HUMAN; MALE; MULTICENTER STUDY; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRE; SEX DIFFERENCE; STATISTICAL MODEL; UNITED STATES;

AGE FACTORS; AGED; ANXIETY; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CROSS-SECTIONAL STUDIES; DEPRESSION; DISTRICT OF COLUMBIA; FEMALE; HUMANS; LINEAR MODELS; MALE; MARYLAND; QUALITY OF LIFE; QUESTIONNAIRES; SEX FACTORS;

EID: 84918843154     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0000000000000107     Document Type: Article

References (29)

1. Calo L, Lamberti F, LoricchioML, et al. Long-term follow-up of right atrial ablation in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15:37-43.
2. Pappone C, Rosanio S, Augello G, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol. 2003; 42:185-197.
3. Tada H, Naito S, Kurosaki K, et al. Segmental pulmonary vein isolation for paroxysmal atrial fibrillation improves quality of life and clinical outcomes. Circ J. 2003;67:861-865.
4. Calkins H, Canby R, Weiss R, et al. Results of catheter ablation of typical atrial flutter. Am J Cardiol. 2004;94:437-442.
5. OCallaghan PA, Meara M, Kongsgaard E, et al. Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutter. Heart. 2001;86:167-171.
6. Natale A, Newby KH, Pisano E, et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol. 2000;35:1898-1904.
7. Dorian P, Paquette M, Newman D, et al. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J. 2002;143:984-990.
8. Paquette M, Roy D, Talajic M, et al. Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation. Am J Cardiol. 2000;86:764-768.
9. Havranek EP, Spertus JA, Masoudi FA, Jones PG, Rumsfeld JS. Predictors of the onset of depressive symptoms in patients with heart failure. J AmColl Cardiol. 2004;44:2333-2338.
10. Frasure-Smith N, Lesperance F, Habra M, et al. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation. 2009;120:134-140. 3p following 140.
11. Kang Y, Bahler R. Health-related quality of life in patients with newly diagnosed atrial fibrillation. Eur J Cardiovasc Nurs. 2004;3:71-76.
12. Ong L, Irvine J, Nolan R, et al. Gender differences and quality of life in atrial fibrillation: the mediating role of depression. J Psychosom Res. 2006;61:769-774.
13. Lange HW, Herrmann-Lingen C. Depressive symptoms predict recurrence of atrial fibrillation after cardioversion. J Psychosom Res. 2007;63(5):509-513.
14. Thrall G, Lip GY, Carroll D, Lane D. Depression, anxiety, and quality of life in patients with atrial fibrillation. Chest. 2007;132:1259-1264.
15. Suzuki S, Kasanuki H. The influences of psychosocial aspects and anxiety symptoms on quality of life of patients with arrhythmia: investigation in paroxysmal atrial fibrillation. Int J Behav Med. 2004;11(2):104-109.
16. Ware JE, Kosinski M. Interpreting SF-36 summary health measures: a response. Qual Life Res. 2001;10:405-413. Discussion 415-420.
17. Turner-Bowker D, Bartley P, Ware J. SF-36 Health Survey & "SF" Bibliography. 3rd ed. Lincoln, RI: Quality Metric Incorporated; 2002.
18. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36), III: tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40-66.
19. Bubien R, Knotts-Dolson S, Plumb V, Kay G. Effects of radiofrequency catheter ablation on health-related quality of life and activities of daily living in patients with recurrent arrhythmias. Circulation. 1996;94:1585-1591.
20. Groth-Marnat G. Handbook of Psychological Assessment. 4th ed. Philadelphia, PA: John Wiley and Sons; 2003.
21. Ramanaiah NV, Franzen M, Schill T. A psychometric study of the State-Trait Anxiety Inventory. J Pers Assess. 1983; 47:531-535.
22. Rule WR, Traver MD. Test-retest reliabilities of State-Trait Anxiety Inventory in a stressful social analogue situation. J Pers Assess. 1983;47:276-277.
23. Beck A, Steer R, Carbin M. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1998;8:77-100.
24. Thomas SA, Chapa DW, Friedmann E, et al. Depression in patients with heart failure: prevalence, pathophysiological mechanisms, and treatment. Crit Care Nurs. 2008;28(2):40-55.
25. Volgman AS, Manankil MF, Mookherjee D, Trohman RG. Women with atrial fibrillation: greater risk, less attention. Gend Med. 2009;6:419-432.
26. Frasure-SmithN, Lesperance F. Depression and anxiety as predictors of 2 year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry. 1999;65:62-71.
27. Walker LG. The measurement of anxiety. Postgrad Med J. 1990;66(suppl 2):S11-S17.
28. Fuster V, Rydén L, Cannom D, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillationVexecutive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines. Circulation. 2006;114:700-752
29. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118:1768-1775.